0001209191-23-014885.txt : 20230302
0001209191-23-014885.hdr.sgml : 20230302
20230302175854
ACCESSION NUMBER: 0001209191-23-014885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230302
DATE AS OF CHANGE: 20230302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jennifer A.
CENTRAL INDEX KEY: 0001841557
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 23700707
MAIL ADDRESS:
STREET 1: C/O NUVATION BIO INC.
STREET 2: 1500 BROADWAY, SUITE 1401
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-28
0
0001811063
Nuvation Bio Inc.
NUVB
0001841557
Fox Jennifer A.
C/O NUVATION BIO INC.
1500 BROADWAY, SUITE 1401
NEW YORK
NY
10036
0
1
0
0
Chief Financial Officer
Class A Common Stock
4481
D
Stock Option (Right to Buy)
1.94
2023-02-28
4
A
0
600000
0.00
A
2033-02-27
Class A Common Stock
600000
600000
D
Includes 2,774 shares acquired on May 19, 2022 and 1 share acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Jennifer A. Fox, by /s/ Ron A. Metzger, Attorney-in-Fact
2023-03-02